[Event Report] The 25th Special Breakfast Meeting: “Japanese System of Vaccination: Future perspective and challenges”
date : 5/28/2014
![[Event Report] The 25th Special Breakfast Meeting: “Japanese System of Vaccination: Future perspective and challenges”](https://hgpi.org/en/wp-content/uploads/sites/2/20140528BFM 011.JPG)
HGPI invited Dr. Yasuhiro Suzuki, Director
General, Health, Medical and Environmental Affairs, Ministry of Defense, to
present on the Japanese system of vaccination and share his thoughts on the
current and present challenges and opportunities.
Dr. Suzuki has worked as Assistant Manager in the Secretariat Headquarters of Pandemic Influenza Preparedness and Response, Ministry of Health, Labour and Welfare. He was also Chief of Medical Technologies and Pharmaceuticals specializing in vaccine and biologics.
Date: Wednesday, May 28, 2014
Time: 8:00am – 9:15am
Normal
0
0
2
false
false
false
EN-US
JA
X-NONE
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:標準の表;
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:””;
mso-padding-alt:0mm 5.4pt 0mm 5.4pt;
mso-para-margin:0mm;
mso-para-margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:10.5pt;
mso-bidi-font-size:11.0pt;
font-family:”Century”,”serif”;
mso-ascii-font-family:Century;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Century;
mso-hansi-theme-font:minor-latin;
mso-font-kerning:1.0pt;}
Speaker:
Yasuhiro Suzuki (Director General, Health,
Medical and Environmental Affairs, Ministry of Defense)
Normal
0
0
2
false
false
false
EN-US
JA
X-NONE
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:標準の表;
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:””;
mso-padding-alt:0mm 5.4pt 0mm 5.4pt;
mso-para-margin:0mm;
mso-para-margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:10.5pt;
mso-bidi-font-size:11.0pt;
font-family:”Century”,”serif”;
mso-ascii-font-family:Century;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Century;
mso-hansi-theme-font:minor-latin;
mso-font-kerning:1.0pt;}
Venue: Hotel New Otani Tokyo,
Room LAPIS3, The Main, 16F
Exhibition date：2014-05-28
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
![[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_3rd_nominations_eyecatch_caseB_ENG_web_20260929_v0.5.jpg)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
![[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261001_Eyecatch_HGPIseminer-146th-1.png)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
![[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261016_Policy-Column-2-Blood-Disorders.png)
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)
![[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/PolicyRecommendations_IntractableAndRareDiseas.jpg)
